Clik here to view.
NAMSA上海实验室开张，扩大在华服务项目
俄亥俄州托莱多和上海 (美国商业资讯) – 全球唯一的医学研究组织(MRO) NAMSA欣然宣布，该组织最先进的临床前医疗器械研究实验室在中国上海开张。这是该组织在亚太区的第三个据点，代表NAMSA对基于中国的实验室服务不断增加投资，并且致力于帮助客户更有效率地将产品推向全球市场。...
View ArticleClik here to view.
Evaluate Ltd Receives Significant Investment from HgCapital to Expand...
LONDON & BOSTON & SAN FRANCISCO & TOKYO Evaluate Ltd, the life science commercial intelligence firm, today announced that it has received significant investment from HgCapital’s Mercury...
View ArticleTaro Provides Results for September 30, 2016
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2016. Quarter...
View ArticleClik here to view.
サンバイオ、再生細胞薬SB623の外傷性脳損傷用途特許をオーストラリアで取得
カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社およびその子会社であるSanBio Inc.）は、この度、独自に開発を進めている再生細胞薬SB623（以下、「本剤」）について、外傷性脳損傷を対象とした特許をオーストラリア特許庁から取得しましたのでお知らせいたします（特許番号2013263417、2016年９月８日取得）。...
View ArticleClik here to view.
Media’s Positive Role Highlighted at Glittering Aster Media Awards Ceremony
DUBAI, United Arab Emirates The inaugural edition of Aster Media Awards saw luminaries emphasizing the critical role of media in ensuring inclusiveness in society and reiterated the immense impact...
View ArticleClik here to view.
Cell Culture Company (C3) Deal Targets Pancreatic Cancer
MINNEAPOLIS Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, announced today it has entered into an agreement with a China-based joint venture to produce a clinical-grade...
View ArticleClik here to view.
Clik here to view.
ファインデックス、日本訪問看護財団・愛媛県訪問看護協議会と共にクラウドサービス型の在宅アセスメントシステムを開発
東京 （ビジネスワイヤ） – 株式会社ファインデックス（東証一部：3649 本社：東京･愛媛 社長：相原輝夫）は、公益財団法人日本訪問看護財団（理事長：清水嘉与子）および一般社団法人愛媛県訪問看護協議会（会長：大西満美子）と共に、客観的な評価を根拠とした訪問看護計画の立案を可能にする「在宅アセスメントシステム」を開発いたしました。...
View ArticleClik here to view.
Celltrion Healthcare Showcases Data Supporting Efficacy and Safety of Both...
WASHINGTON New data presented today at the 2016 American College of Rheumatology (ACR) Annual Meeting demonstrate that the efficacy and safety profile of CT-P10 (biosimilar rituximab) in rheumatoid...
View ArticleClik here to view.
Clik here to view.
Irish-Based Novaerus and Vinamedical Perform Signing Ceremony in Hanoi, Vietnam
DUBLIN Today, Novaerus and their local strategic partner Vinamedical recognized the introduction of Irish-based Novaerus technology in Vietnam with a signing ceremony at the Presidential Palace in...
View ArticleClik here to view.
[KOREA TL Plastic Surgery]‘Nothing Can Replace SMAS Face Lifting!’
SEOUL, South Korea If you look older than your age due to drooping skin and deep wrinkles, your best option would be a superficial muscular aponeurotic system-SMAS face lifting. This Smart News...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
マシモがゲイツ財団から疾病負担が大きい地域向けの併用型肺炎スクリーニングデバイス開発のための助成金を受け取る
米カリフォルニア州アーバイン （ビジネスワイヤ） — マシモ（NASDAQ:...
View ArticleClik here to view.
HeartFlow FFRct Analysis Receives Regulatory Approval in Japan
REDWOOD CITY, Calif. HeartFlow, Inc. has announced the approval of its HeartFlow® FFRct Analysis by the Japanese Ministry of Health, Labour and Welfare (MHLW). The HeartFlow FFRct Analysis is the...
View ArticleClik here to view.
Mitsui to Join KKR and Panasonic as an Investor in Panasonic Healthcare
TOKYO Mitsui & Co., Ltd. (“Mitsui”), one of Japan’s largest diversified corporations, and global investment firm KKR today announced the signing of a definitive share purchase agreement for...
View ArticleClik here to view.
Clik here to view.
ゴアのGlobal Registry for Endovascular Aortic Treatmentが患者組み入れを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、VEITHsymposium®にて、Global Registry for Endovascular Aortic Treatment...
View ArticleClik here to view.
Last Chance to Fix Failed Rhinoplasty: 3D Procedure – TL Plastic Surgery Korea
SEOUL, South Korea As a facial feature that sits front and center, any bump, misalignment, or other flaw in your nose can dramatically decrease your self-confidence. And because you need your nose...
View Article